Education
About Us
Working with TipRanks
Follow Us
Genfit (GNFT)
:GNFT
Single Dose G1090n, Multiple Dosing Of G1090n
Acute-On-Chronic Liver Failure
Phase I
Not Yet Recruiting
Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers
Jul 25, 2025
―
Gns561 + Trametinib
Cholangiocarcinoma
Phase I/II
Recruiting
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Apr 27, 2023
―
Nitazoxanide
Renal Impairment, Kidney Disease, Renal Disease
Phase I
Completed
Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects
Apr 12, 2022
―
Nitazoxanide
Liver Diseases, Moderate Hepatic Impairment, Severe Hepatic Impairment
Phase I
Completed
Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients
Nov 01, 2021
―
Elafibranor
Healthy, Geriatrics
Phase I
Completed
Elafibranor Pharmacokinetic Parameters in Elderly Healthy Volunteers
Nov 19, 2019
―
Elafibranor, Chrono-Indocid
Drug-Drug Interaction
Phase I
Completed
Study to Investigate the Potential Drug-Drug Interaction Between Elafibranor and Indomethacin
Jun 11, 2019
―
Elafibranor 120Mg
Non-Alcoholic Fatty Liver
Phase II
Terminated
Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)
May 15, 2019
―
Elafibranor 80Mg, Elafibranor 120Mg
Non Alcoholic Steatohepatitis
Phase II
Terminated
Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH)
Mar 13, 2019
―
Elafibranor
Pharmacokinetics, Renal Impairment, Kidney Diseases, Renal Insufficiency
Phase I
Completed
Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients
Feb 15, 2019
―
Elafibranor
Hepatic Impairment, Pharmacokinetics, Liver Disease
Phase I
Completed
Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients
Nov 30, 2018
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Genfit (GNFT) have in its pipeline
GNFT is currently developing the following drugs: Single Dose G1090n, Multiple Dosing Of G1090n, Gns561 + Trametinib, Nitazoxanide. These drug candidates are in various stages of clinical development as the company works toward FDA approval.